Package 77771-423-60

{"route": ["ORAL"], "spl_id": "2db3da6f-14f6-4c55-ad22-55e475ad9f09", "openfda": {"nui": ["N0000175427", "N0000190114", "N0000185503", "N0000182137", "N0000187061"], "upc": ["0377771424602", "0377771423605"], "unii": ["A6IEZ5M406"], "rxcui": ["616749", "728231"], "spl_set_id": ["38d2833d-44b8-8d46-e063-6394a90a74d8"], "pharm_class_epc": ["Anti-anginal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Radha Pharmaceuticals, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE (77771-423-60)", "package_ndc": "77771-423-60", "marketing_start_date": "20250630"}], "brand_name": "RANOLAZINE", "product_id": "77771-423_2db3da6f-14f6-4c55-ad22-55e475ad9f09", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Anti-anginal [EPC]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "77771-423", "generic_name": "RANOLAZINE", "labeler_name": "Radha Pharmaceuticals, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RANOLAZINE", "active_ingredients": [{"name": "RANOLAZINE", "strength": "500 mg/1"}], "application_number": "ANDA211829", "marketing_category": "ANDA", "marketing_start_date": "20250630", "listing_expiration_date": "20271231"}